Your browser doesn't support javascript.
loading
Sarcoma Care Practice in India During COVID Pandemic: A Nationwide Survey.
Gulia, Ashish; Tiwari, Akshay; Arora, Ramandeep Singh; Gupta, Srinath; Raja, Anand.
Afiliação
  • Gulia A; Dept of Surgical Oncology, Tata Memorial Hospital, and Homi Bhabha National Institure (HBNI), Mumbai, India.
  • Tiwari A; Musculoskeletal Oncology, Max Institute of Cancer Care, Saket, New Delhi, India.
  • Arora RS; Paediatric Oncology, Max Super Speciality Hospital, New Delhi, India.
  • Gupta S; Dept of Surgical Oncology, Tata Memorial Hospital, and Homi Bhabha National Institure (HBNI), Mumbai, India.
  • Raja A; Department of Surgical Oncology, Cancer Institute (WIA), Adyar, Chennai, India.
Indian J Orthop ; 54(Suppl 2): 350-357, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32836364
BACKGROUND: Amidst the COVID-19 pandemic, management of cancer has been one of the most intensely debated topics across the globe. We conducted an online survey to determine the consistency/or the lack of it, in the management of sarcoma patients between centres and the changes in policies. METHODS: A twenty-five question online survey was conducted among practicing physicians over a period of 10 days using online portal (surveymonkey.com). It was followed by a critical analysis based on responses to each question. RESULTS: Of 194 medical professionals who participated, 80% were surgeons and 53% were working in government institutes. Most respondents (81%) continued their practice with some modifications. In OP majority (67%) relied only on symptom, contact enquiry and temperature recording for screening. COVID-19 testing was done more (43%) in IP patients. Most of institutes (83%) followed rotational policy to reduce the number of staff at risk while 57% offered an alternate accommodation. 52.3% continued chemotherapy for all patients while radiotherapy for all was offered by 45%. In metastatic cases, majority preferred either no treatment or non-surgical intervention (71%).84.5% believed in adapting changes (42%-avoid supra major surgeries, 27%-Operating only emergency cases and 15.5%-High grade sarcomas with curative intent) in surgical management of sarcomas. For benign bone tumors, majority (71%) agreed on adapting changes while 25% agreed on deferring all cases. 69% preferred teleconsultations for follow-up. Complete PPE were being used for all aerosol generating procedures by 44%. Only two thirds agreed with their institutes policy of PPE usage and COVID-19 testing. CONCLUSION: This survey has highlighted disparity on COVID-19 screening and management in various institutes across the country. This will act as a reference point for tracking future trends in bone and soft tissue tumor management guidelines, as the COVID-19 scenario unfolds globally and particularly in India.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Qualitative_research Idioma: En Revista: Indian J Orthop Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Qualitative_research Idioma: En Revista: Indian J Orthop Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Índia